Historical Stock Price
CTMX historical stock prices picture
CytomX Therapeutics (CTMX) has the following price history information. Looking back at CTMX historical stock prices for the last five trading days, on March 22, 2024, CTMX opened at $2.21, traded as high as $2.21 and as low as $2.10, and closed at $2.11. Trading volume was a total of 287.80K shares. On March 25, 2024, CTMX opened at $2.13, traded as high as $2.15 and as low as $2.09, and closed at $2.14. Trading volume was a total of 358.60K shares. On March 26, 2024, CTMX opened at $2.16, traded as high as $2.16 and as low as $1.99, and closed at $2.11. Trading volume was a total of 645.90K shares. On March 27, 2024, CTMX opened at $2.12, traded as high as $2.20 and as low as $2.08, and closed at $2.19. Trading volume was a total of 590.30K shares. On March 28, 2024, CTMX opened at $2.20, traded as high as $2.30 and as low as $2.17, and closed at $2.18. Trading volume was a total of 2.85M shares.

CTMX Historical Stock Prices By Date:

CTMX historical cagr picture

Below, we examine the compound annual growth rate — CAGR for short — of an investment into CytomX Therapeutics shares, starting with a $10,000 purchase of CTMX, and working forward through the historical stock price information to today.

Growth of $10,000.00
Without Dividends Reinvested

Start date: 10/09/2015
End date: 03/28/2024
Start price/share: $12.40
End price/share: $2.18
Dividends collected/share: $0.00
Total return: -82.42%
Average Annual Total Return: -18.55%
Starting investment: $10,000.00
Ending investment: $1,757.49
Years: 8.47
Date Open High Low Close Volume
03/22/2024 $2.21 $2.21 $2.10 $2.11 287.80K
03/25/2024 $2.13 $2.15 $2.09 $2.14 358.60K
03/26/2024 $2.16 $2.16 $1.99 $2.11 645.90K
03/27/2024 $2.12 $2.20 $2.08 $2.19 590.30K
03/28/2024 $2.20 $2.30 $2.17 $2.18 2.85M
CytomX Therapeutics is a clinical-stage, oncology-focused biopharmaceutical company. Co. is developing an antibody-based therapeutics created using its Probody® therapeutic technology platform. Co.'s products include: Praluzatamab ravtansine, which is an activated antibody-drug conjugates directed against CD166, a tumor target previously considered undruggable due to its high expression on normal tissues; CX-2029, which opens a therapeutic window for targeting CD71; Pacmilimab, which is a Probody therapeutic against PD-L1, a clinically and commercially validated cancer target; and BMS-986249 and BMS-986288, which is the Probody versions of ipilimumab.
Date Close
03/22/2024$2.11
03/25/2024$2.14
03/26/2024$2.11
03/27/2024$2.19
03/28/2024$2.18
CTMX is categorized under the Healthcare sector; below are some other companies in the same sector:

CTRV Historical Stock Prices
CTRX Historical Stock Prices
CTSO Historical Stock Prices
CTXR Historical Stock Prices
CUR Historical Stock Prices
CUTR Historical Stock Prices
CVD Historical Stock Prices
CVM Historical Stock Prices
CVRS Historical Stock Prices
CWBR Historical Stock Prices

Also explore: CTMX shares outstanding history

Email EnvelopeFree CTMX Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts


CTMX Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2024, All Rights Reserved

Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 9.5%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 9.5%.